EVE Health Group Limited Stock Price

ASX:EVE Community·AU$6.6m Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Create a narrative

EVE Share Price Performance

AU$0.027

-0.01 (-32.50%)

AU$0.027

-0.01 (-32.50%)

AU$0.027

Sun, 26 Oct 25

Share PriceAU$0.027

EVE Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Snowflake Analysis

Flawless balance sheet with low risk.

3 Risks

1 Reward

View Full Analysis

EVE Health Group Limited Key Details

Last Reported Earnings

Jun 30, 2025

Next Reporting Earnings

n/a

: -0.0059
: 47.50%
: -83.76%
: 2.6%

View Full Analysis

About EVE

Founded: 2003
Employees: n/a
CEO: n/a
WebsiteView website: www.evehealthgroup.com.au

EVE Health Group Limited, together with its subsidiaries, engages in the development, retail, and commercialization of health and wellness, and pharmaceutical products. The company lead product is Dyspro, a proprietary pharmaceutical-grade formulation to address dysmenorrhea (menstrual pain); and Libbo, a proprietary pharmaceutical-grade oral dissolving film formulation for the treatment of erectile dysfunction. It also offers Lactobacillus rhamnosus Beebiotic MAP01, a proprietary strain to support digestive health and vitality. The company was formerly known as EVE Investments Limited. EVE Health Group Limited was incorporated in 2003 and is based in Subiaco, Australia.